Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1574094 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.90Day −1.01%Mkt cap $41M1Y −26.4%Off 52W high −38.1%Vol (1Y) 80.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,228 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.7% of sh out |
| Days to cover1.7d |
| 13F net flow (QoQ)+4.63% |
| Top-10 13F concentration95.0% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.5M |
| Earnings (TTM)-$12.3M |
| ROE−225.6% |
| Net margin−994.5% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+6.9% |
| 1Y−26.4% |
| 3Y−54.6% |
| Since incept. (ann.)−35.4% |
Total return through 2026-07-29 · series begins 2021-08-27. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)80.4% |
| Ann. volatility (3Y)97.9% |
| Sharpe (1Y)−0.02 |
| Sharpe (3Y)0.20 |
| Max drawdown (1Y)−45.3% |
| Max drawdown (3Y)−72.9% |
| Beta (3Y vs SPY)2.05 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| AIGH Capital Management LLC | 3.7M | $4M | 8.22% | +30.8% |
| Bleichroeder LP | 1.7M | $2M | 3.69% | +177.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $1M | 3.21% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 381,723 | $385,561 | 0.85% | +2.8% |
| Wealthspire Advisors, LLC | 252,525 | $255,051 | 0.56% | +0.0% |
| CITADEL ADVISORS LLC | 232,684 | $235,011 | 0.52% | +335.7% |
| VANGUARD FIDUCIARY TRUST CO | 157,902 | $159,481 | 0.35% | new |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 99,460 | $100,455 | 0.22% | +33.3% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.09 | — | $563,000 | +185.8% |
| 2025-12-31 | 2026-03-30 | — | — | $238,000 | — |
| 2025-09-30 | 2025-11-13 | −$0.08 | — | $266,000 | — |
| 2025-06-30 | 2025-08-14 | −$0.08 | — | $422,000 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
All Other Segments 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
